R. Aranda
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Immunology top 10%
- T-cell and B-cell Immunology
- Biosimilars and Bioanalytical Methods
Papers in
-
- Rheumatoid Arthritis Research and Therapies 7
- Genetics 4
- Inflammatory Bowel Disease 4
- Co-authors
- J-C Becker (4 shared papers)Maxime Dougados (2 shared papers)A. Covucci (1 shared paper)Edward Clark Keystone (1 shared paper)Michael E. Weinblatt (2 shared papers)Jean‐Claude Becker (1 shared paper)Bernard G Combe (1 shared paper)Beate C. Sydora (3 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Lara D. Veeken (2 papers)Gastroenterology (1 paper)Clinical & Experimental Immunology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
R. Aranda
13 papers receiving 1.6k citations
R. Aranda's Hit Papers
Peers
Comparison fields: 5 of 68
- Rheumatology 1.2k
- Immunology 263
- Genetics 216
- Immunology and Allergy 25
- Hematology 34
Countries citing papers authored by R. Aranda
This map shows the geographic impact of R. Aranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Aranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Aranda more than expected).
Fields of papers citing papers by R. Aranda
This network shows the impact of papers produced by R. Aranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Aranda. The network helps show where R. Aranda may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Aranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Hit paper breakdown → | 2007 | 451 |
| 2 | 2006 | 327 | |
| 3 | 1997 | 283 | |
| 4 | 2007 | 220 | |
| 5 | 2011 | 171 | |
| 6 | 2007 | 122 | |
| 7 | 2006 | 84 | |
| 8 | 2002 | 44 | |
| 9 | 2016 | 34 | |
| 10 | Immunosuppressive drugs in the treatment of inflammatory bowel disease. | 1998 | 8 |
| 11 | 2006 | 5 | |
| 12 | 2010 | 2 | |
| 13 | 1995 | 1 |
About R. Aranda
R. Aranda is a scholar working on Rheumatology, Genetics, Immunology and Allergy, Pharmacology and Surgery, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Inflammatory Bowel Disease (4 papers), Drug-Induced Hepatotoxicity and Protection (1 paper), Cell Adhesion Molecules Research (1 paper) and Eosinophilic Esophagitis (1 paper). The work is most often cited by research in Rheumatology (1.2k citations), Immunology (263 citations), Genetics (216 citations), Immunology and Allergy (25 citations) and Hematology (34 citations). R. Aranda has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include J-C Becker, Maxime Dougados, A. Covucci, Edward Clark Keystone, Michael E. Weinblatt, Jean‐Claude Becker, Bernard G Combe, Beate C. Sydora, J. Teng and Mitchell Kronenberg. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Gastroenterology, Clinical & Experimental Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.